Data at the 2022 ASCO Annual Meeting highlight Roche’s continued commitment to innovation in oncology and personalised healthcare May 24, 2022May 24, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Data at the 2022 ASCO Annual Meeting highlight…Data at the 2022 ASCO Annual Meeting highlight…Roche to present new OCREVUS (ocrelizumab) data in…Roche to present new Evrysdi data at MDA 2022 and…New data for Roche’s Columvi and Lunsumio presented…Xylem to Highlight Resilient Digital Solutions for…
